Covered recipient · General Payments record
ENEIDA DEPINA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health
General Payments · PY2021–2024
$955.68
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $289.23 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exeltis, USA Inc. | $74.38 | 4 |
| Hologic Sales and Service, LLC | $35.03 | 1 |
| Merck Sharp & Dohme Corporation | $33.67 | 2 |
| Organon LLC | $32.44 | 2 |
| Ethicon US, LLC | $27.41 | 1 |
| Sage Therapeutics, Inc. | $19.31 | 1 |
| Evofem Biosciences, Inc. | $17.00 | 1 |
| Agile Therapeutics, Inc. | $17.00 | 1 |
| Olympus America Inc. | $16.98 | 1 |
| CooperSurgical, Inc. | $16.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Agile Therapeutics, Inc. | $17.00 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154841186 | CMS |
| CooperSurgical, Inc. | $16.01 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150784088 | CMS |
| Ethicon US, LLC | $27.41 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077639084 | CMS |
| Evofem Biosciences, Inc. | $17.00 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091277656 | CMS |
| Exeltis, USA Inc. | $17.00 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150011263 | CMS |
| Exeltis, USA Inc. | $15.69 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150011265 | CMS |
| Exeltis, USA Inc. | $23.48 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150011267 | CMS |
| Exeltis, USA Inc. | $18.21 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150011269 | CMS |
| Hologic Sales and Service, LLC | $35.03 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084904482 | CMS |
| Merck Sharp & Dohme LLC | $15.94 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141557542 | CMS |
| Merck Sharp & Dohme LLC | $17.73 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141557544 | CMS |
| Olympus America Inc. | $16.98 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108489268 | CMS |
| Organon Llc | $16.68 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136193207 | CMS |
| Organon Llc | $15.76 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136193209 | CMS |
| Sage Therapeutics, Inc. | $19.31 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120390535 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.